The FDA has extended the deadline for manufacturers, repackagers, and other distributors to place a drug product identifier at the individual package level for each product introduced into interstate commerce.

Beginning November 27, 2017, manufacturers are required to “affix or imprint a product identifier to each package and homogenous case of product intended to be

The Drug Supply Chain Security Act (DSCSA) is also known as Track-and-Trace law. It creates a system to identify and trace certain prescription drugs to improve detection and removal of potentially dangerous products from the pharmaceutical distribution supply chain.  The DSCSA has two parts.
Phase I is product tracing. Manufacturers, wholesalers, repackagers, and many